Brewer GJ - Search Results

1

Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.

Brewer GJ, Hedera P, Kluin KJ, Carlson M, Askari F, Dick RB, Sitterly J, Fink JK. Brewer GJ, et al. Arch Neurol. 2003 Mar;60(3):379-85. doi: 10.1001/archneur.60.3.379. Arch Neurol. 2003. PMID: 12633149 Clinical Trial.

2

Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin: further support for existence of a new zinc overload syndrome.

Hedera P, Fink JK, Bockenstedt PL, Brewer GJ. Hedera P, et al. Among authors: brewer gj. Arch Neurol. 2003 Sep;60(9):1303-6. doi: 10.1001/archneur.60.9.1303. Arch Neurol. 2003. PMID: 12975299

3

Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc.

Askari FK, Greenson J, Dick RD, Johnson VD, Brewer GJ. Askari FK, et al. Among authors: brewer gj. J Lab Clin Med. 2003 Dec;142(6):385-90. doi: 10.1016/S0022-2143(03)00157-4. J Lab Clin Med. 2003. PMID: 14713890

4

Atypical childhood Wilson's disease.

Carlson MD, Al-Mateen M, Brewer GJ. Carlson MD, et al. Among authors: brewer gj. Pediatr Neurol. 2004 Jan;30(1):57-60. doi: 10.1016/s0887-8994(03)00422-3. Pediatr Neurol. 2004. PMID: 14738953

5

Wilson's disease: clinical management and therapy.

Brewer GJ, Askari FK. Brewer GJ, et al. J Hepatol. 2005;42 Suppl(1):S13-21. doi: 10.1016/j.jhep.2004.11.013. Epub 2004 Dec 18. J Hepatol. 2005. PMID: 15777568 Review. No abstract available.

6

Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.

Brewer GJ, Askari F, Lorincz MT, Carlson M, Schilsky M, Kluin KJ, Hedera P, Moretti P, Fink JK, Tankanow R, Dick RB, Sitterly J. Brewer GJ, et al. Arch Neurol. 2006 Apr;63(4):521-7. doi: 10.1001/archneur.63.4.521. Arch Neurol. 2006. PMID: 16606763 Clinical Trial.

7

Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.

Brewer GJ, Askari F, Dick RB, Sitterly J, Fink JK, Carlson M, Kluin KJ, Lorincz MT. Brewer GJ, et al. Transl Res. 2009 Aug;154(2):70-7. doi: 10.1016/j.trsl.2009.05.002. Epub 2009 Jun 6. Transl Res. 2009. PMID: 19595438

8

White matter changes in Wilson disease.

Hedera P, Brewer GJ, Fink JK. Hedera P, et al. Among authors: brewer gj. Arch Neurol. 2002 May;59(5):866-7. doi: 10.1001/archneur.59.5.866. Arch Neurol. 2002. PMID: 12020274 No abstract available.

9

Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients.

Brewer GJ, Dick RD, Johnson V, Wang Y, Yuzbasiyan-Gurkan V, Kluin K, Fink JK, Aisen A. Brewer GJ, et al. Arch Neurol. 1994 Jun;51(6):545-54. doi: 10.1001/archneur.1994.00540180023009. Arch Neurol. 1994. PMID: 8198464

10

Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy.

Brewer GJ, Johnson V, Dick RD, Kluin KJ, Fink JK, Brunberg JA. Brewer GJ, et al. Arch Neurol. 1996 Oct;53(10):1017-25. doi: 10.1001/archneur.1996.00550100103019. Arch Neurol. 1996. PMID: 8859064 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

473 results

Search Page